Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trial.
Journal: The Lancet. Microbe
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Lindesmith LC, Zweigart MR, Brewer-Jensen PD, et al. (2026). "Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trial.". The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2025.101337